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Abstract
Neurophysiological measurements of the response to prepulse and startle stimuli have been 
suggested to represent an important endophenotype for both substance dependence and other 
select psychiatric disorders. We have previously shown, in young adult Mexican Americans (MA), 
that presentation of a short delay acoustic prepulse, prior to the startle stimuli can elicit a late 
negative component at about 400 msec (N4S), in the event-related potential (ERP), recorded from 
frontal cortical areas. In the present study we investigated whether genetic factors associated with 
this endophenotype could be identified. The study included 420 (age 18 – 30 years) MA men 
(n=170) and women (n=250). DNA was genotyped using an Affymetrix Axiom Exome1A chip. 
An association analysis revealed that the CCKAR and CCKBR (cholecystokinin A and B receptor) 
genes each had a nearby variant that showed suggestive significance with the amplitude of the 
N4S component to prepulse stimuli. The neurotransmitter cholecystokinin (CCK), along with its 
receptors, CCKAR and CCKBR, have been previously associated with psychiatric disorders, 
suggesting that variants near these genes may play a role in the prepulse/startle response in this 
cohort.
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The identification of neurophysiological endophenotypes associated with psychiatric 
disorders may help in determining the causal relationship between clinical phenomena 
associated with the disorder and basic molecular processes that are in large part determined 
by genetic factors. One psychophysiological measure that has been used as a potential 
endophenotype for a number of psychiatric disorders is the acoustic startle reflex (ASR) and 
prepulse inhibition of the startle (PPI). The startle reflex is a constellation of responses 
usually indexed by eye blink responses (Swerdlow et al., 1992), but also by 
electrophysiological recordings from cortical areas that may index cognitive responses to 
startle (Ehlers et al., 2011; Ford et al., 1999; Ford et al., 1994; Putnam & Roth, 1990). 
Prepulse inhibition of the startle (PPI) refers to the fact that if a weak stimulus is presented 
prior to the presentation of the startle stimuli (prepulse) the response to the startle is reduced 
in amplitude. It has been suggested that prepulse inhibition is an index of automatic 
sensorimotor gating (Geyer & Swerdlow, 2001). In prepulse facilitation (PPF), the response 
to the startle is enhanced by short or long delay prepulses. PPF has been suggested to reflect 
a combination of alerting, attention and/ or arousal (Filion et al., 1998; Hsieh et al., 2006; 
Ludewig et al., 2003).
The anatomical substrates of the neurobehavioral responses (ASR/PPI/PPF) to the 
presentation of the startle stimuli have been extensively investigated in clinical and 
preclinical studies (Braff, Geyer, Light, et al., 2001; Braff, Geyer, & Swerdlow, 2001; 
Kumari et al., 2005; Swerdlow et al., 1994). Startle responses involve a complex neural 
network extending from brainstem nuclei via the thalamus to higher order cortical areas that 
may regulate cognitive responses to startle (Campbell et al., 2007; Fendt et al., 2001; 
Kumari et al., 2005; Neuner et al., 2010; Schall et al., 1999). There is some evidence that the 
cognitive response to ASR/PPI may share a common underlying neurophysiology with some 
behavioral and clinical measures of cognition that require response inhibition (Filion et al., 
1999). For instance, both performance on 3 the Wisconsin Card Sorting Task and PPI of 
startle have been suggested to reflect prefrontal cortical function and dysfunction (Filion et 
al., 1999; Swerdlow & Geyer, 1999). Impairments in frontal lobe function and associated 
behaviors, such as executive functioning, have been an important theoretical construct in the 
understanding a number of behavioral disorders, such as schizophrenia (Bagney et al., 2013; 
Chan et al., 2014; Eisenberg & Berman, 2010; Holmen et al., 2012; Owens et al., 2010), 
bipolar disorders (Erol et al., 2014; Kulkarni et al., 2010; Yen et al., 2009; Zimmerman et 
al., 2006) and substance use disorders (Fernandez-Serrano et al., 2010; Gierski et al., 2013; 
Loeber et al., 2009; Maurage et al., 2014; van der Plas et al., 2009; Zorko et al., 2004). If 
frontal cortical responses to the startle stimuli index some aspect of frontal lobe functioning 
involving higher cognition, then psychiatric disorders postulated to involve some aspects of 
frontal lobe dysfunction should also have startle deficits such as anxiety disorders (De 
Pascalis et al., 2013), schizophrenia (De Koning et al., 2014; Swerdlow et al., 2014), post-
traumatic stress disorder (Grillon et al., 1996), and alcoholism (Ehlers et al., 2011; Marin et 
al., 2012).
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The present investigation used a startle paradigm with short delay prepulse-plus-startle 
stimuli, that elicits a large frontal negative slow wave designated the N4S component 
(Ehlers et al., 2011). In the present study, we used this endophenotype in an association 
analysis using an Affymetrix Axiom Exome1A array, to explore potential genetic factors 
underlying the N4S component response to prepulse startle stimuli in a young adult Mexican 
American cohort that has been previously well characterized clinically (Criado & Ehlers, 
2007; Criado et al., 2014; Ehlers et al., 2009, 2010; Ehlers et al., 2012; Ehlers & Phillips, 
2007; Ehlers et al., 2011; Ehlers et al., 2014).
MATERIALS AND METHODS
Sample ascertainment
To investigate risk and protective factors for the prepulse inhibition and startle response in a 
select population of Mexican American young adults, we investigated a cohort of 420 (age 
18 – 30) Mexican American men (n=170) and women (n=250). Participants were recruited 
using a commercial mailing list that provided the addresses of individuals with Hispanic 
surnames in 11 zip codes in San Diego County. The mailed invitation stated that potential 
participants must be of Mexican American heritage, between the ages of 18 and 30 years, 
residing in the United States legally, and able to read and write in English. Based on a phone 
interview, participants were excluded if they were pregnant, were nursing, or currently had a 
major medical or neurological disorder or head injury. All participants identified as having 
over 20% Hispanic heritage, with 92% reporting over 50% Hispanic heritage. The Semi-
Structured Assessment for the Genetics of Alcoholism (SSAGA) (Bucholz et al., 1994), was 
used to make lifetime substance use and other psychiatric disorder diagnoses according to 
DSM-III-R and DSM-IV criteria. There have been several studies that have evaluated the 
concurrent diagnostic validity of the SSAGA across alcohol and drug dependencies, major 
depression, anxiety disorders, and antisocial personality disorder (Bucholz et al., 1994; 
Hesselbrock et al., 1999). These findings indicate that the SSAGA is a highly reliable and 
valid instrument for use in studies of psychiatric disorders, including substance dependence. 
The protocol for the study was approved by the Institutional Review Board (IRB) at The 
Scripps Research Institute, and written consent was obtained for all participants. Participants 
were asked to refrain from alcohol and drug usage for 24 hours prior to the testing.
Startle ERP collection and analysis
Recordings were obtained from participants who were seated on a hospital bed in a sound-
attenuated room. Acoustic startle stimuli were presented binaurally through headphones. 
The behavioral response to the startle (eye blink) is recorded using electrodes placed below 
and lateral to the eye as described (Braff, Geyer, & Swerdlow, 2001). The auditory stimuli 
consist of 45 trials. These trials include randomly presented startle stimuli (115 dB white 
noise burst for 40 msec n=30) and prepulse-startle stimuli (85 dB white noise burst for 20 
msec-duration) immediately (<5 msec) followed by the startle (115 dB white noise burst for 
40 msec n=15). Each individual startle and/or prepulse startle trial is separated by an interval 
of 15 seconds. Background white noise was presented for the entire session at a level of 60 
dB. The behavioral variables assessed included: ASR magnitude on startle trials and 
prepulse trials as determined by quantification of the eye blink response as described below.
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Seven channels of ERP data (FZ, CZ, PZ, F3, F4, F7, and F8, referenced to linked ear lobes 
with a forehead ground, international 10–20 system) were obtained using gold-plated 
electrodes with impedance held below 5 KΩ. Frontal electrodes were emphasized in the 
montage as previous data had suggested that ERP decrements in frontal areas distinguished 
subjects with a risk for alcohol dependence (Bauer, 1997). An electrode placed left lateral 
infraorbitally and reference to the left earlobe was used to monitor both horizontal and 
vertical eye movements. ERP signals were amplified (time constant 0.3 s, 35 Hz low pass) 
using a Nihon Kohden EEG machine and were transferred on-line to a PC. The combined 
gain of the EEG amplifiers and the analog-to-digital multiplexer amplifier was 50K.
The eye blink and ERP trials were simultaneously digitized at a rate of 256 Hz (bandwidth 
0.5–35 Hz). Individual trials where the EEG or eye blink exceeded ±250 microvolts (<5% of 
the trials) were eliminated before averaging. The N4S component of the ERP was quantified 
using a computerized peak detection routine that identifies baseline-to-peak amplitudes (in 
μV) within the specified latency window (350–500 msec). The eye blink amplitude was also 
assessed using this routine. The latency window for the eye blink was 50–120 msec. The 
baseline was determined by averaging the 150 ms of pre-stimulus activity obtained for each 
trial. The routine is user-driven and each peak detection must be verified by the user. All 
peaks were quantified by one investigator, and verified by a second investigator, both of 
whom were blind to participants’ characteristics.
The N4S component of the ERP was also evaluated to determine if it was altered as a 
function of alcohol dependence, antisocial personality disorder/conduct disorder (ASPD/
CD), affective/anxiety disorders (ANYAXAF), and any other drug dependence 
(AnyDrugDep). In this analysis, regionally averaged N4S component responses to startle 
and prepulse/startle were compared between those participants with and without the 
psychiatric disorders using ANCOVA (co-varying for gender).
Sample preparation and genotyping
For all subjects, DNA was extracted from blood samples, followed by genotyping using an 
Affymetrix Exome1A chip. The DNA samples were prepared and the exome chip 
genotyping was performed on the Affymetrix Axiom Exome 1A Array according to the 
Affymetrix Axiom 2.0 Assay Manual Workflow documentation. The Affymetrix Exome 1A 
chip contains 247,222 markers. Variant quality from the exome chip genotyping was 
initially assessed according to Affymetrix best practices (Affymetrix, 2011). Plink version 
1.07 (Purcell et al., 2007) was used to calculate Hardy-Weinberg (HWE) p-values on the set 
of unrelated samples, followed by the removal of 653 variants with an HWE p < 10−10.
Association analysis
PLINK was used to test for genome-wide association for the N4S component of the event-
related potential (ERP) in response to acoustic startle stimuli following the presentation of a 
prepulse. PLINK was run with linear regression model parameters and with one million 
permutations. Gender and age were included as covariates. To determine the effect of 
extreme outliers in the phenotypic values, custom R code was written to generate winsorized 
phenotype values at 5% and 95% cutoffs, which were then used as the phenotype values in 
Norden-Krichmar et al. Page 4













PLINK. Manhattan plots were generated using Manhattan R library (Stephen Turner, http://
gettinggeneticsdone.blogspot.com/2011/04/annotated-manhattan-plots-and-qq-plots.html). 
Annotations of the variants were obtained from the Affymetrix Exome 1A chip description 
file. Multiple test correction p-value thresholds were calculated for the Affymetrix 
Exome1A chip using the Genetic Type 1 Error Calculator (GEC) software (Li et al., 2012). 
The UCSC Genome Browser (Kent et al., 2002) was also utilized to visualize the genomic 
region containing the significant SNPs.
In order to determine if the SNPs that were significantly associated with the pre-pulse 
response phenotype were shared with the alcohol dependence trait, we used the multivariate 
version of the PLINK software (Ferreira & Purcell, 2009) with covariates age and gender.
LD analysis
In order to check for linkage disequilibrium across the CCKAR and CCKBR gene regions, 
PLINK was utilized to extract a subset of variants for analysis based on the physical position 
of these genes on chromosomes 4 and 11, respectively. In particular, a region of 
chromosome 4 from genomic location 25,450,000–28,000,000 and chromosome 11 from 
genomic location 6,100,000–6,500,000, were extracted from the data set. Haploview 
(Barrett et al., 2005) was used to calculate the LD statistics and visualize the haplotype 
block structure of the gene regions.
RESULTS
Demographics of the Mexican American population
The demographics for the full sample of individuals (N=420) that were included in the 
association analysis are shown in Table 1. The subjects were a mean age of 23.6 (range 18 – 
30) years at the time of interview, with 40% of the sample being male and 60% of the 
sample being female. Participants had a mean of 13.3 years of education (SD=1.8), and a 
mean income of $30,000-$49,000. Using self-reported ancestry based on grandparent origin, 
92% of the participants reported at least 50% Hispanic heritage. The mean BMI was 27 
(SD=7, range 17 – 64). Approximately 29% (N=123) of the participants were diagnosed 
with alcohol dependence according to DSM-III-R guidelines, indicating that these subjects 
had symptoms from 3 or more symptom groups, out of 9 possible symptom groups. Eleven 
percent (N=45) of the participants were diagnosed with conduct disorder or antisocial 
personality disorder/conduct disorder. Thirty-one percent (N=132) of the participants has a 
lifetime diagnosis of affective and/or anxiety disorder. Twenty-seven percent (N=115) of the 
participants had a diagnosis of another drug disorder (nicotine, cannabis, hallucinogens, 
stimulants, sedatives, opioids).
The mean N4S amplitude was evaluated using ANCOVA (co-varying with gender) as a 
function of alcohol dependence, ASPD/CD, any affective and/or anxiety disorder, and any 
other drug dependency. Participants with a lifetime diagnosis of alcohol dependence had 
significantly increased amplitude N4S responses to prepulse/startle stimuli as compared to 
participants with no alcohol dependence diagnoses (F=6.535; p=0.011). There were no 
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significant associations between the N4S amplitude to prepulse stimuli phenotypic trait and 
ASPD/CD, ANYAXAF, or AnyDrugDep diagnoses.
Association analysis
Figure 1 contains the Manhattan plot for the amplitude of the N4S response to prepulse 
stimuli phenotypic trait tested in the association analysis across the entire genome, using 
covariates age and gender, and applying a minor allele cutoff of 0.01. Although there were 5 
total variants which exhibited p-values <= E-05 after association, as shown in Table 2, there 
were only two variants (rs2171755 and rs58905541) that showed suggestive significance 
and possessed plausible gene functions for this phenotype. One protective variant 
(rs2171755; NC_000004.12:g.26502338T>C) is located 12kb upstream from the CCKAR 
gene in a MIRb class SINE repetitive element, and is common in our sample, with an allele 
frequency of 0.36. The rs58905541 variant is a risk variant (NC_000011.10:g.6296157C>T) 
located 24kb downstream from the CCKBR gene in a DNaseI hypersensitivity cluster, with 
an allele frequency of 0.018. The variant retained its significance through permutation and 
winsorization and the exclusion of covariates age and gender. The association values for 
these two variants, along with the allele and genotype frequencies, are shown in Table 3. 
The minor allele frequencies of these variants in the 1000 Genomes project was obtained 
from the dbSNP website (http://www.ncbi.nlm.nih.gov/SNP/).
From the multivariate association analysis of the N4S response to prepulse stimuli 
phenotypic trait and alcohol dependence diagnosis phenotype, we found that the inclusion of 
the alcohol dependence phenotype did not significantly alter the association of the SNPs 
with the prepulse phenotype. That is, the p-values were significant whether we used 
univariate PLINK (rs2171755 p-value=1.79E-05; rs58905541 p-value=1.11E-06), or 
multivariate PLINK (rs2171755 p-value=9.36E-05; rs58905541 p-value=5.77E-06). 
Additionally, the weights determined by multivariate PLINK demonstrated that the prepulse 
phenotype had a strong correlation to the SNPs (rs2171755 weight for prepulse = 0.995; 
rs58905541 weight for prepulse = 0.999), while the alcohol dependence phenotype had a 
very weak correlation (rs2171755 weight for alcohol dependence = 0.026; rs58905541 
weight for alcohol dependence = 0.109). These results suggest that the prepulse phenotype is 
driving the significance of the association for these two SNPs.
Multiple test correction
Multiple test correction p-value thresholds were calculated for the Affymetrix Axiom 
Exome1A chip using the Genetic Type 1 Error Calculator (GEC) software (Li et al., 2012), 
and the thresholds generated were thereby used to determine that the variants could be 
characterized to possess suggestive significance. In particular, for the Affymetrix Axiom 
Exome1A chip at a minor allele frequency of 0.01 or greater, the threshold for a suggestive 
p-value was calculated as 2.53E-05, significant p-value as 1.27E-06, and highly significant 
p-value as 2.53E-08.
LD analysis
The linkage disequilibrium (LD) was calculated across the CCKAR and CCKBR gene 
regions. The average D’ value across the SNP pairs in the CCKAR region was 0.77 in this 
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data set. No other SNPs on the Affymetrix chip were found to be in high LD with the variant 
near the CCKAR gene. The average D’ value across the SNP pairs in the CCKBR region was 
0.85 in this data set. While no SNP was found to be in complete LD with rs58905541, the 
SNP with highest LD was rs1462983 (D’=0.837, r2=0.023, LOD=2.19, CI=0.37–0.95). This 
SNP was located in OR56B4 (olfactory receptor, family 56, subfamily B, member 4) and 
possessed a positive beta value, suggesting it is a risk factor. However, rs1462932 was not 
significantly associated with the prepulse inhibition response phenotype in our sample when 
using PLINK for the analysis.
DISCUSSION
The present study confirmed previous observations in this population of an increase in 
prepulse facilitation of the N4S ERP component to the acoustic prepulse stimuli (Ehlers et 
al., 2011). In the present study, we used this endophenotype in an association analysis using 
an Affymetrix Axiom Exome1A array, to explore potential genetic factors underlying the 
N4S component response to prepulse startle stimuli in this young adult Mexican American 
cohort. The results of the present study suggest that variants located near CCKAR and 
CCKBR (cholecystokinin A and B receptor) genes are suggestive to be associated with the 
N4S ERP response to prepulse startle stimuli in this Mexican American cohort. The 
rs2171755 variant (NC_000004.12:g.26502338T>C) is located 12kb upstream from the 
CCKAR gene in a MIRb class SINE repetitive element. Interestingly, a variant in a MIRb 
class SINE repetitive element has been reported to be associated with human cognition 
(Gosso et al., 2007). The rs58905541 variant (NC_000011.10:g.6296157C>T) is located 
24kb downstream from the CCKBR gene in a DNaseI hypersensitivity cluster. Variants in 
regulatory regions of the genome, such as DNase I hypersensitive sites, have been found to 
be associated with a number of diseases (Consortium, 2012; Maurano et al., 2012). 
Additionally, both SNPs show phylogenetic conservation in the UCSC Genome Browser 
alignment tracks in Figure 2. Since it has been reported that phenotype-associated variants 
occur more frequently in evolutionarily constrained regions of the genome (Parker et al., 
2009), it suggests that these SNPs are likely to be real and functional. Therefore, it is 
feasible that the non-coding variants found in this present study could potentially play a role 
in the N4S ERP response to prepulse stimuli.
The neurotransmitter cholecystokinin (CCK) is widely present in the human body and in the 
central nervous system, where it modulates the dopaminergic system (Crawley & Corwin, 
1994). Because of its potential modulation of the dopaminergic system and associated 
reward pathways, CCK has been investigated in a number of studies as a candidate gene for 
substance dependence and other behavioral disorders. CCK, along with its two receptors, 
CCKAR and CCKBR, have been previously associated with anxiety and panic disorders 
(Maron et al., 2008; Wilson et al., 2012), schizophrenia (Christoforou et al., 2007; Sanjuan 
et al., 2004), nicotine dependence (Takimoto et al., 2005), and alcohol dependence 
(Miyasaka et al., 2004; Okubo & Harada, 2001; Okubo et al., 2002). Although one study 
reported no association between CCK and CCKBR with alcohol dependence (Vanakoski et 
al., 2001), the study was performed using a Finnish population and did not examine the 
same significant SNPs that were determined in our study. Besides possible neurological 
influences of CCK on alcohol addiction, it has also been found that CCK through activation 
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of CCKA receptors protects the gastric mucosa against ethanol-induced gastric damage in 
rats (Konturek et al., 1995). In the context of alcoholism, variation in CCK activity in the 
gut could allow for the ingestion of greater or lesser amounts of alcohol, which in turn could 
influence liability towards alcoholism.
Further evidence of the role of CCK in the regulation of startle responses is supported by 
studies where the administration of CCK-related peptides has been found to influence the 
startle response in rats and humans. In particular, infusion of CCK has been found to 
enhance the acoustic startle response in rats (Feifel et al., 2001; Feifel & Swerdlow, 1997; 
Fendt et al., 1995), and some CCK antagonists attenuate startle responses (Feifel et al., 
1999; Josselyn et al., 1995). In human subjects, CCK infusion has also been demonstrated to 
increase eye-blink startle as well as produce a mild increase in anxiety and heart rate as well 
as increases in plasma concentrations of ACTH, cortisol, prolactin and growth hormone 
(Shlik et al., 1999). Since CCK peptides have been demonstrated to enhance anxiety, several 
studies have investigated the role of the CCK system in anxiety and panic disorders, using 
CCK-related peptide administration as a challenge method (Koszycki et al., 2012; Maron et 
al., 2008). These CCK challenge studies were able to explore genetic factors in panic 
disorders by performing candidate gene analyses to find alleles that may be associated with 
greater sensitivity to the CCK peptides. One study found an association of the tryptophan 
hydroxylase gene isomer 2 (TPH2) with subjects experiencing panic attacks after CCK 
infusion (Maron et al., 2008). Another study found an association to the CCKBR gene in 
subjects with greater pre-challenge anxiety (Koszycki et al., 2012). Additional studies have 
utilized CCK-peptide infusion to determine its effects on EEG and ERP measures in healthy 
human subjects (Knott et al., 2002; Knott et al., 2003). CCK-4 infusion was found to delay 
the latencies of N100 and P200 components of the ERP that was elicited during an auditory 
oddball task (Knott et al., 2002). During EEG recording of resting subjects, CCK-4 infusion 
was also found to increase asymmetry and reduce coherence of the slow-wave activity at 
mid-temporal recording sites (Knott et al., 2003). Taken together, these studies suggest a 
plausible role for CCK variants in the regulation of brain activity and behavior.
Impairments in frontal lobe function and associated behaviors such as executive functioning 
have been suggested to underlie anxiety disorders (Castaneda et al., 2008) as well as a 
number of other behavioral disorders such as schizophrenia (Bagney et al., 2013; Chan et 
al., 2014; Eisenberg & Berman, 2010; Holmen et al., 2012; Owens et al., 2010), bipolar 
disorders (Erol et al., 2014; Kulkarni et al., 2010; Yen et al., 2009; Zimmerman et al., 2006) 
and substance use disorders (Fernandez-Serrano et al., 2010; Gierski et al., 2013; Loeber et 
al., 2009; Maurage et al., 2014; van der Plas et al., 2009; Zorko et al., 2004). Interestingly, 
schizophrenia and bipolar disorders also demonstrate significant clinical comorbidity with 
substance use disorders (Regier et al., 1990) and may also share genetic susceptibility 
factors (Schizophrenia Working Group of the Psychiatric Genomics, 2014; Schuckit et al., 
2003). There is also some data to suggest that they may share common endophenotypes such 
as deficits in some aspects of responses to startle (Kohl et al., 2013), although this 
hypothesis requires further testing and confirmation.
In summary, in the present study, associations between the N4S ERP response to acoustic 
prepulse startle stimuli, were determined using association analyses. Our results suggest that 
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variants located in regulatory non-coding regions near the cholecystokinin A and B 
receptors may play a role in the prepulse/startle response. However, the results of this study 
should be interpreted in the context of several limitations. First, the findings may not 
generalize to the general American population of mixed heritage or all Mexican Americans, 
or all Hispanic young adult Americans. Over half of the participants in the present were 
women and thus findings many not generalize to previous studies that have focused on 
samples of entirely male participants. Second, the study was limited to young adults between 
the ages of 18 and 30 years, and the sample size may limit the interpretation of the results. 
Despite these limitations, this report represents an important step in an ongoing investigation 
to determine risk and protective factors associated with development of substance use 
disorders in this select Mexican American population.
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Figure 1. Manhattan plot for prepulse phenotype
Manhattan plot across all chromosomes, using covariates age and gender. Minor allele 
frequency cutoff of 0.01 applied to the plot. Suggestive significance line calculated from 
GEC software. Green rectangles in plot highlight SNPs rs2171755 and rs58905541.
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Figure 2. UCSC Genome Browser view of the SNP locations
This figure shows the genomic location of the SNPs rs2171755 and rs58905541.
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Table 1
Demographics for Mexican American study participants
Male Female Total
Participants 170 (40%) 250 (60%) 420
Age: mean(sd), [range] 23.7 (3.9), [18–30] 23.5 (3.8), [18–30] 23.6 (3.8), [18–30]
Self-reported MA heritage >= 50% 90.60% 92.60% 91.60%
BMI: mean(sd), [range] 27.6 (6.0) [17.3–52.3] 27.2 (7.4) [16.9–64.4] 27.3 (6.9) [16.9–64.4]
Education in years: mean(sd), [range] 13.2 (1.7), [9–17] 13.4 (1.8), [7–18] 13.3 (1.8), [7–18]
Income: mean(sd), [range] 4.8 (2.1), [1–9] 4.2 (2.1), [0–9] 4.4 (2.2) [0–9]
Alcohol Dependence, # of subject affected 63 [63/170 = 37%] 60 [60/250 = 24%] 123 [123/420 = 29.3%)
Pre-pulse inhibition: mean(sd), [range] 13.07 (8.38), [0.01–50.63] 15.48 (9.18), [0.01–60.12] 14.51 (8.93), [0.01–60.12]
Startle: mean(sd), [range] 12.28 (6.70), [0.01–36.28] 15.12 (8.00), [0.01–47.09] 13.97 (7.62), [0.01–47.09]
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Table 3
Allele frequencies, genotype frequencies, and association analysis results
dbSNP RS ID rs2171755 rs58905541
Minor Allele C T
1000GENOMES AF (ALL) 0.455 0.129
1000GENOMES AF (AMR) 0.403 0.044
Present Study Sample
 Overall MAF 0.361 0.018
 Genotype counts 59/185/176 0/15/405
 Frequency 0.1405/0.4405/0.419 0/0.03571/0.9643
 HWE p-value 0.3463 1
Association analysis with no covars








Number of permutations performed 901,000 1,000,000
Empirical adaptive P-value 4.44E-05 1.30E-05
Association analysis with covars
(Unscaled Beta, P-value)
Additive −2.658, 1.789E-05 11.24, 1.114E-06
Sex 2.675, 2.155E-03 2.167, 1.207E-02
Age −0.07525, 0.5007 −0.06604, 0.5519
(Scaled Beta, P-value)
Additive −0.2068, 1.789E-05 0.2337, 1.114E-06
Sex 0.1471, 2.155E-03 0.1192, 1.207E-02
Age −0.03204, 0.5007 −0.02812, 0.5519
The minor allele frequencies from the 1000 Genomes project, 1000GENOMES AF (ALL=total subjects and AMR=Admixed American subjects) 
were obtained from the 1000Genomes website (http://www.1000genomes.org/).
Abbreviations: MAF=minor allele frequency; HWE=Hardy-Weinberg equilibrium.
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